Multiple Sclerosis 
The MD Magazine Multiple Sclerosis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Renewed Interest in Multiple Sclerosis Drug
MS: Did a pharma giant back away from a drug candidate too soon?
Oral ozanimod treatment can reduce MS relapse rates.
Fingolomid appears to reduce the harmful activities of astrocytes in MS.
Australian researchers are closing in on a blood test for multiple sclerosis.
Oral contraceptives do not worsen multiple sclerosis and may help stop relapses.
Rival drugs for MS were equally effective, study found.
Off-label use of Ritalin for MS did not help patients.
Placebo did better than promising drug in treating MS fatigue.
Patients with multiple sclerosis say they do better on daclizumab.

Most Popular


$vacMongoViewPlus$ $vAR$